Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for detecting coupling distribution of intermediate T-MCC of antibody coupling medicine T-DM1

A T-DM1, antibody coupling technology, applied in the field of medicine, can solve problems such as interference, affecting accuracy, background fluorescence, etc., and achieve the effects of easy operation, cost saving, and product quality assurance

Pending Publication Date: 2021-02-02
TOT BIOPHARM CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantage of this method is: due to the presence of dyes in the system and the influence of the endogenous fluorescence of the protein, the background has fluorescence interference
The degree of derivatization reaction between the fluorescent dye and the protein will also affect the accuracy of the detection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting coupling distribution of intermediate T-MCC of antibody coupling medicine T-DM1
  • Method for detecting coupling distribution of intermediate T-MCC of antibody coupling medicine T-DM1
  • Method for detecting coupling distribution of intermediate T-MCC of antibody coupling medicine T-DM1

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Example 1 Carry out reduced CE-SDS analysis to T-MCC synthesized by different production processes and corresponding T-DM1

[0056] Reduction of the test solution preparation:

[0057] T-MCC sample 1 (18mg / mL): Take 50 μL of T-MCC sample 1, add 175 μL of water, and dilute to 4 mg / mL. According to the preparation method of the reduced test solution, take 25 μL of diluted T-MCC sample 1, add 70 μL of SDS sample buffer, 5 μL of β-mercaptoethanol, and mix well. Heat at 65°C for 10min.

[0058] T-MCC sample 2 (19.5 mg / mL): Take 50 μL of T-MCC sample 2, add 194 μL of water, and dilute to 4 mg / mL. Take 25 μL, add 70 μL of sample buffer, 5 μL of β-mercaptoethanol, and mix well. Heat at 65°C for 10min.

[0059] T-MCC sample 3 (17.6mg / mL): Take 50 μL of T-MCC sample 3, add 170 μL of water, and dilute to 4 mg / mL. Take 25 μL, add 70 μL of sample buffer, 5 μL of β-mercaptoethanol, and mix well. Heat at 65°C for 10min.

[0060] T-DM1 sample 1 (22.0 mg / mL): Take 50 μL of T-DM1 ...

Embodiment 2

[0081] Reduction of the test solution preparation:

[0082] Test solution 1: Take 50 μL of T-MCC sample 1, add 175 μL of water, and dilute to 4 mg / mL. Take 25 μL of diluted T-MCC sample 1, add 70 μL of SDS sample buffer, 5 μL of β-mercaptoethanol, and mix well. Heat at 65°C for 10min.

[0083] Test solution 2: Take 50 μL of T-MCC sample 1, add 175 μL of water, and dilute to 4 mg / mL. Take 25 μL of diluted T-MCC sample 1, add 70 μL of SDS sample buffer, 5 μL of dithiothreitol, and mix well. Heat at 65°C for 10min.

[0084] Test solution 3: Take 50 μL of T-MCC sample 1, add 175 μL of water, and dilute to 4 mg / mL. Take 25 μL of diluted T-MCC sample 1, add 70 μL of SDS sample buffer, 5 μL of β-mercaptoethanol, and mix well. Heat at 60°C for 10min.

[0085] Test solution 4: take 50 μL of T-MCC sample 1, add 175 μL of water, and dilute to 4 mg / mL. Take 25 μL of diluted T-MCC sample 1, add 70 μL of SDS sample buffer, 5 μL of β-mercaptoethanol, and mix well. Heat at 70°C for 10...

Embodiment 3

[0094] Reduction of the test solution preparation:

[0095] Test solution: Take 50 μL of T-MCC sample 1, add 175 μL of water, and dilute to 4 mg / mL. Take 25 μL of diluted T-MCC sample 1, add 70 μL of SDS sample buffer, 5 μL of β-mercaptoethanol, and mix well. Heat at 65°C for 10min.

[0096] Capillary cartridge installation: Use 50 μm ID uncoated fused silica capillary (such as uncoated capillary 50 μm ID from SCIEX), cut to a total length of 30 cm and an effective length of 20 cm. The detection window is equipped with hole plug No. 2 (100 μm × 200 μm).

[0097] Assay 1: PA800plus is analyzed using capillary electrophoresis. The capillary temperature is 20°C, the sample chamber temperature is 10°C, and the detection wavelength is 220nm. Rinse the capillary with 0.1M NaOH solution at 70psi pressure for 3min, wash the capillary with 0.1M HCl solution at 70psi pressure for 1min, wash the capillary with ultrapure water at 70psi pressure for 1min, and fill it with gel buffer at...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicines, in particular to a method for detecting coupling distribution of an intermediate T-MCC of an antibody coupling medicine T-DM1. According to the detection method provided by the invention, protein treated by adding a reducing agent is associated with SDS in a sample buffer solution, separation is carried out in a capillary tube filled with gel according to the molecular weight, and the protein can be directly detected through an ultraviolet detector due to the fact that the protein is absorbed at the ultraviolet wavelength of 220nm. The method issimple and convenient to operate, the macromolecular covalent fragment formed by linker mismatch in the T-DM1 intermediate T-MCC can be quickly analyzed, and the coupling rate DAR of the final product T-DM1 can be analyzed in advance according to the content of the macromolecular covalent fragment. The method is applied to intermediate coupling distribution analysis of the antibody coupling drugT-DM1, a reference basis can be provided for process optimization and control, the cost is saved, and the product quality is guaranteed.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a detection method for the coupling distribution of an intermediate T-MCC of an antibody-coupled drug T-DM1. Background technique [0002] T-DM1 is an antibody-drug conjugate (ADC) in which Trastuzumab is coupled to 0-8 small molecule toxins DM1 through a linker SMCC (linker). The coupling process is as follows: (1) SMCC undergoes a modification reaction with the lysine site on the antibody to obtain T-MCC; (2) T-MCC and DM1 undergo a chemical coupling reaction to obtain T-DM1. [0003] The small molecule conjugation distribution and drug-antibody conjugation ratio (DAR) of T-DM1 are key quality attributes of T-DM1, which need to be controlled within a certain size range. The analysis of the linker coupling of the intermediate T-MCC can provide a basis for process optimization, control the production process, and ensure the quality of the final product. [0004] Currently, icIEF and LC...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N27/447G01N33/487
CPCG01N27/44721G01N27/447G01N33/48707G01N2550/00Y02A50/30
Inventor 张弛周维黄鹏刘军
Owner TOT BIOPHARM CO LTD